These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9774965)

  • 1. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Refludan: pharmacologic surveillance study].
    Winicki J
    Presse Med; 1998 Jun; 27 Suppl 2():31-2. PubMed ID: 9765664
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant hirudin in clinical practice: focus on lepirudin.
    Greinacher A; Lubenow N
    Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended and actual lepirudin doses in patients with renal insufficiency.
    Saxer SB; Smith BS; Gandhi PJ; Tataronis GR; Krikorian SA
    Am J Health Syst Pharm; 2003 Dec; 60(24):2588-93. PubMed ID: 14735776
    [No Abstract]   [Full Text] [Related]  

  • 7. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
    Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
    Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 10. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 11. Lepirudin in the management of heparin-induced thrombocytopenia.
    Gajra A; Husain J; Smith A
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
    Greinacher A
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis].
    Lubenow N; Greinacher A
    Hamostaseologie; 2002 Aug; 22(3):44-54. PubMed ID: 12215761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for patients with heparin-induced thrombocytopenia marketed.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1444. PubMed ID: 9676284
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery.
    Sun Y; Greilich PE; Wilson SI; Jackson MR; Whitten CW
    Anesth Analg; 2001 Feb; 92(2):344-6. PubMed ID: 11159229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In AT-III deficiency: heparin or hirudin?].
    Spannagel U
    MMW Fortschr Med; 1999 Oct; 141(42):14. PubMed ID: 10912097
    [No Abstract]   [Full Text] [Related]  

  • 19. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG; van de Loo A; Böhler J
    Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.